Propel a Cure for Crohn’s Disease

1/ Thanks to your support, we’re funding four groundbreaking research projects—each taking a different path to uncover the root causes of #Crohns & develop targeted, non-immunosuppressive treatments that go beyond symptom mgmt. Here’s how each project is making a difference →

“What can we learn from #IBD before diagnosis?” In our interview, Dr. Joana Torres shares how studying the preclinical stage helps uncover how IBD begins—mapping immune changes and pinpointing inflammatory pathways driving disease. Full video: propelacure.org/videos…

New research highlights a copper-triggered form of cell death—cuproptosis—as a promising treatment for #IBD. Copper can both fuel and fight disease, and targeting this process could open new therapeutic pathways. news-medical.net/news/20250718/…

🧬 What can early life tell us about #IBD? Dr. Joana Torres is investigating how early life factors & at-risk populations may hold the key to predicting who develops IBD & how the disease unfolds. Her research focuses on identifying early signals of IBD in newly diagnosed…

Ecco consensus guideline on diet in #IBD is out now! huge work by @EmmaHalmos @PaedsRH and so many others..glad to be a small cog in this mammoth effort. academic.oup.com/ecco-jcc/advan…

📣 Paid research study opportunity for Crohn’s disease, Ulcerative colitis, and Micriscopic colitis patients: Propel a Cure partners with @rarepatientvoic to connect #IBD patients & caregivers with research opportunities that align with their condition or that of a loved one. By…

Over 90% of adults carry Epstein-Barr Virus (#EBV), often without symptoms. But in a subset of genetically susceptible people, EBV may play a role in triggering Crohn’s disease—just like it’s been linked to other autoimmune conditions like multiple sclerosis and lupus.…

🔵 Interested in Global IBD and future scenarios? Very happy to see our review published in @UEGJournal with IBD Master and good friend @ibdseb 👍

We’re excited to share that Propel a Cure & IBD Connect are officially organizational partners! By uniting our efforts, we’re strengthening both sides of the fight against #IBD by providing critical support for families today & fueling groundbreaking research for tomorrow. Our…

We’re committed to being a stable funder and champion of promising biomedical research. We invite applications for our Innovator Awards from Aug 1-Sept 30. Grants will support individual and collaborative research that advances the understanding of #IBD. krfoundation.org/news/health/ib…

A shout-out to @UBC researchers who are refining a targeted drug delivery system -- GlycoCaging -- that could avert the systemic side effects of steroids and other #IBD medications. globalnews.ca/video/11160379… #crohns #crohnsdisease #ulcerativecolitis

Will it ever be possible to find a definitive cure for #inflammatoryboweldiseases? Find out most recent developments towards this ambitious goal in our latest review edited by @dnoviello_93 Chiara Amoroso @federicafacciot and Maurizio Vecchi. sciencedirect.com/science/articl….

“Poor psychological health is highly prevalent at the time of an #IBD diagnosis, demonstrating genuine gut-brain effects.”

Recruitment for randomized controlled trials in #IBD has decreased over time, impeding progress in research. Patients are lost at every step—from being excluded due to complications, to opting out over concerns about placebo assignment. The time for restructuring this process is…

Once thought to be a condition only seen in Western nations, IBD progression is now found all around the world. Here’s why. healthcentral.com/news/inflammto…

Researchers at @broadinstitute & @MassGenBrigham used single-cell & spatial transcriptomics to map intestinal tissue from #Crohns patients, identifying 68 cell types including fibroblast subtypes linked to #fibrosis & #strictures. They also found genetic variants active in these…